Earnings History Data for Evotec SE (EVO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Evotec SE

EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
08-11-2023 PM EVO Evotec SE 3,140 N/A -0.03 0.00 Evotec SE reports 9M results
[11/8/2023 9:08 AM]
9.27 0.57 
(6.55%)
9.31 0.61 
(7.01%)
7.80 - 13.49 42,461 30,000 7,899
29-08-2023 PM EVO Evotec SE 4,010 N/A 0.04 0.00 Evotec SE reports 1H results; updates FY23 guidance
[8/29/2023 3:27 AM]
11.99 0.55 
(4.81%)
11.20 -0.24 
(-2.10%)
7.80 - 13.49 91,438 30,000 1,167
09-11-2022 PM EVO Evotec SE 3,360 N/A 0.08 0.00 Evotec SE reports 9M results; outlook for FY2022 unchanged and mid-term targets 2025 confirmed
[11/9/2022 3:28 AM]
8.65 -0.88 
(-9.23%)
8.66 -0.87 
(-9.13%)
7.83 - 25.29 133,747 40,000 20,912
11-08-2022 PM EVO Evotec SE 4,730 N/A -0.01 0.22 Evotec SE reports 1H results; updates FY22 guidance and mid-term targets of 2025 confirmed
[8/11/2022 2:03 AM]
13.12 -0.01 
(-0.08%)
12.95 -0.18 
(-1.37%)
10.60 - 26.57 51,991 50,000 6,588